Hybio Pharmaceutical Co., Ltd. (SHE:300199)
17.46
+0.26 (1.51%)
Mar 9, 2026, 3:04 PM CST
43.94% (1Y)
| Market Cap | 15.42B |
| Revenue (ttm) | 898.10M |
| Net Income (ttm) | -67.50M |
| Shares Out | 883.24M |
| EPS (ttm) | -0.08 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,966,432 |
| Average Volume | 19,785,186 |
| Open | 17.05 |
| Previous Close | 17.20 |
| Day's Range | 16.39 - 17.61 |
| 52-Week Range | 10.50 - 31.19 |
| Beta | 0.86 |
| RSI | 39.11 |
| Earnings Date | Apr 25, 2026 |